TRACK RECORD : MONITORING AND PREDICTING SEIZURES IN EPILEPSY
In collaboration with epilepsy specialist Professor Mark Cook, researchers at the Bionics Institute developed the first-generation Epi-Minder device, which went into clinical trials in 2019 to monitor seizures in epilepsy.
![First-generation epilepsy device](https://neo-bionica.com/wp-content/uploads/2021/12/First-generation-epilepsy-device.png)
CLINICAL CHALLENGE
Professor Mark Cook, Director of Neurology at St Vincent’s Hospital, identified the need for a medical device to record seizures in epilepsy patients over months and years. This is because neurologists currently rely on self-reported occurrences and EEG recordings taken during clinic visits to titrate seizure control medication.
CLINICAL CHALLENGE
Professor Mark Cook, Director of Neurology at St Vincent’s Hospital, identified the need for a medical device to record seizures in epilepsy patients over months and years. This is because neurologists currently rely on self-reported occurrences and EEG recordings taken during clinic visits to titrate seizure control medication.
![First-generation epilepsy device](https://neo-bionica.com/wp-content/uploads/2021/12/First-generation-epilepsy-device.png)
CLINICAL CHALLENGE
Professor Mark Cook, Director of Neurology at St Vincent’s Hospital, identified the need for a medical device to record seizures in epilepsy patients over months and years. This is because neurologists currently rely on self-reported occurrences and EEG recordings taken during clinic visits to titrate seizure control medication.
CLINICAL CHALLENGE
Professor Mark Cook, Director of Neurology at St Vincent’s Hospital, identified the need for a medical device to record seizures in epilepsy patients over months and years. This is because neurologists currently rely on self-reported occurrences and EEG recordings taken during clinic visits to titrate seizure control medication.
![First-generation epilepsy device](https://neo-bionica.com/wp-content/uploads/2021/12/First-generation-epilepsy-device.png)
CLINICAL CHALLENGE
Professor Mark Cook, Director of Neurology at St Vincent’s Hospital, identified the need for a medical device to record seizures in epilepsy patients over months and years. This is because neurologists currently rely on self-reported occurrences and EEG recordings taken during clinic visits to titrate seizure control medication.
CLINICAL CHALLENGE
Professor Mark Cook, Director of Neurology at St Vincent’s Hospital, identified the need for a medical device to record seizures in epilepsy patients over months and years. This is because neurologists currently rely on self-reported occurrences and EEG recordings taken during clinic visits to titrate seizure control medication.
![stock-photo-attractive-smart-young-man-sitting-on-a-floor-in-the-living-room-using-mobile-phone-1674151537](https://neo-bionica.com/wp-content/uploads/2021/12/stock-photo-attractive-smart-young-man-sitting-on-a-floor-in-the-living-room-using-mobile-phone-1674151537.png)
CLINICAL CHALLENGE
Professor Mark Cook, Director of Neurology at St Vincent’s Hospital, identified the need for a medical device to record seizures in epilepsy patients over months and years. This is because neurologists currently rely on self-reported occurrences and EEG recordings taken during clinic visits to titrate seizure control medication.